• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Superconnector
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEW
    Legal
    Terms of usePrivacy policyCookie policy

    Health In Tech Announces Innovative Collaboration with MARPAI and Vitable DPC to Offer Competitive Quotes in Enhanced Self-Funded Solutions

    1/22/25 5:00:00 PM ET
    $HIT
    $MRAI
    Specialty Insurers
    Finance
    Misc Health and Biotechnology Services
    Health Care
    Get the next $HIT alert in real time by email

    STUART, Fla., Jan. 22, 2025 /PRNewswire/ -- Health In Tech, an Insurtech platform company backed by third-party AI technology, is thrilled to announce a new strategic collaboration with Vitable and MARPAI. This collaboration aims to introduce a  competitively priced self-funded health plan to the market. By utilizing the strength of Vitable's Direct Primary Care (DPC), a health plan, and stop-loss coverage, Health In Tech seeks to offer low quotes on their eDIYBS platform, and to set an ambitious standard in affordability and efficiency.

    HIT logo (PRNewsfoto/Health In Tech)

    Vitable's enhanced primary care plan combines in-person and virtual primary care access with mental health programs, free prescription drugs, lab work, and care navigation for the entire household, all under a low monthly fee and $0 out-of-pocket cost for members. With their cost containment ability proven by numerous third-party actuarial firms and reinsurance carriers, our intention is to utilize Vitable's DPC to provide competitively priced quotes within Health In Tech's proprietary eDIYBS platform for networks and carriers under MARPAI's self-funded health plan offerings. We expect Vitable's high utilization and member satisfaction to contribute to reductions in healthcare costs.

    "This collaboration exemplifies our commitment to revolutionizing healthcare access and affordability," said Glenn Hillyer, Chief Growth Officer at Health In Tech. "By integrating Vitable's hybrid DPC model - with their successful track record in effectively managing primary care and urgent care claims for self-funded and level-funded plans - with MARPAI's self-funded health plans, and the streamlined process for which Health In Tech is known for, we are working to deliver competitive value and comprehensive care to our clients."

    Vitable's hybrid DPC model seeks to ensure seamless access to primary care and mental health services, providing members with the flexibility and convenience of both in-home and virtual visits. This approach addresses the critical need for accessible and affordable healthcare, especially for the under- and uninsured workforce.

    "We are excited to join forces with Health In Tech and MARPAI to bring our high-quality health plans at a significantly lower cost," said Steven Baek, Head of Growth at Vitable. "Our commitment is to enhance member satisfaction and utilization while driving down healthcare costs."

    "We are excited to announce our collaboration with both Health In Tech and Vitable, two leaders in the employee benefits space," said Ben Utz, Vice President of Strategic Accounts at Marpai. "Together, we hope to deliver smarter, seamless healthcare experiences that prioritize employee well-being, improve access to personalized care, and drive meaningful results for organizations."

    This competitive quote opportunity will be available through Health In Tech's eDIYBS platform starting today.

    About Health In Tech

    Health In Tech (Nasdaq: "HIT") is an Insurtech platform company backed by third-party AI technology, which offers a marketplace that aims to improve processes in the healthcare industry through vertical integration, process simplification, and automation. By removing friction and complexities, we streamline the underwriting, sales and service process for insurance companies, licensed brokers, and TPAs. Learn more at healthintech.com.

    About Vitable

    Vitable offers a hybrid Direct Primary Care health plan for self-funded and level-funded groups, delivering easy access to high-quality primary care and mental health coverage to the under- and uninsured American workforce. Vitable membership includes in-home and virtual primary care visits, free prescriptions, labs, and mental health programs with no out-of-pocket cost for the members.

    About Marpai, Inc.

    Marpai, Inc. (OTCQX:MRAI) is a technology platform company which operates subsidiaries that provide TPA and value-oriented health plan services to employers that directly pay for employee health benefits. Primarily competing in the $22 billion TPA sector serving self-funded employer health plans representing over $1 trillion in annual claims. Through its Marpai Saves initiative, the Company works to deliver the healthiest member population for the health plan budget. Operating nationwide, Marpai offers access to leading provider networks including Aetna and Cigna, industry leading Reference Based Pricing (RBP) solutions and all TPA services. For more information, visit www.marpaihealth.com, the content of which is not incorporated by reference into this press release. Investors are invited to visit https://www.ir.marpaihealth.com.

    Forward-Looking Statements Regarding Health In Tech

    Certain statements in this press release are forward-looking statements for purposes of the safe harbor provisions under the U.S. Private Securities Litigation Reform Act of 1995. Forward-looking statements may include estimates or expectations about Health In Tech's possible or assumed operational results, financial condition, business strategies and plans, market opportunities, competitive position, industry environment, and potential growth opportunities. In some cases, forward-looking statements can be identified by terms such as "may," "will," "should," "design," "target," "aim," "hope," "expect," "could," "intend," "plan," "anticipate," "estimate," "believe," "continue," "predict," "project," "potential," "goal," or other words that convey the uncertainty of future events or outcomes. These statements relate to future events or to Health In Tech's future financial performance, and involve known and unknown risks, uncertainties and other factors that may cause Health In Tech's actual results, levels of activity, performance, or achievements to be different from any future results, levels of activity, performance or achievements expressed or implied by these forward-looking statements. You should not place undue reliance on forward-looking statements because they involve known and unknown risks, uncertainties and other factors which are, in some cases, beyond Health In Tech's control and which could, and likely will, affect actual results, levels of activity, performance or achievements. Any forward-looking statement reflects Health In Tech's current views with respect to future events and is subject to these and other risks, uncertainties and assumptions relating to Health In Tech's operations, results of operations, growth strategy and liquidity.

    Investor Contact

    Investor Relations:

    [email protected]

     

     

    Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/health-in-tech-announces-innovative-collaboration-with-marpai-and-vitable-dpc-to-offer-competitive-quotes-in-enhanced-self-funded-solutions-302357907.html

    SOURCE Health In Tech

    Get the next $HIT alert in real time by email

    Crush Q3 2025 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $HIT
    $MRAI

    CompanyDatePrice TargetRatingAnalyst
    More analyst ratings

    $HIT
    $MRAI
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chief Executive Officer Lamendola Damien bought $399,999 worth of shares (371,470 units at $1.08) (SEC Form 4)

    4 - Marpai, Inc. (0001844392) (Issuer)

    8/1/25 7:06:13 PM ET
    $MRAI
    Misc Health and Biotechnology Services
    Health Care

    Chief Executive Officer Lamendola Damien bought $99,999 worth of shares (86,805 units at $1.15) (SEC Form 4)

    4 - Marpai, Inc. (0001844392) (Issuer)

    7/21/25 4:05:07 PM ET
    $MRAI
    Misc Health and Biotechnology Services
    Health Care

    Director Howard William D. was granted 128,474 shares (SEC Form 4)

    4 - Health In Tech, Inc. (0002019505) (Issuer)

    6/25/25 9:00:14 PM ET
    $HIT
    Specialty Insurers
    Finance

    $HIT
    $MRAI
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chief Executive Officer Lamendola Damien bought $399,999 worth of shares (371,470 units at $1.08) (SEC Form 4)

    4 - Marpai, Inc. (0001844392) (Issuer)

    8/1/25 7:06:13 PM ET
    $MRAI
    Misc Health and Biotechnology Services
    Health Care

    Chief Executive Officer Lamendola Damien bought $99,999 worth of shares (86,805 units at $1.15) (SEC Form 4)

    4 - Marpai, Inc. (0001844392) (Issuer)

    7/21/25 4:05:07 PM ET
    $MRAI
    Misc Health and Biotechnology Services
    Health Care

    President and COO Powers John Paul was granted 100,000 shares and bought $11,300 worth of shares (10,000 units at $1.13), increasing direct ownership by 73% to 260,000 units (SEC Form 4)

    4 - Marpai, Inc. (0001844392) (Issuer)

    12/9/24 5:15:20 PM ET
    $MRAI
    Misc Health and Biotechnology Services
    Health Care

    $HIT
    $MRAI
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    MARPAI REPORTS SECOND QUARTER 2025 FINANCIAL RESULTS

    Marpai Slashes Losses by Two-Thirds in Q2 2025, Paving the Way to Profitability.Operating Expenses Cut 70% as Turnaround Gains Traction TAMPA, Fla., Aug. 13, 2025 /PRNewswire/ -- Marpai, Inc. ("Marpai" or the "Company") (OTCQX:MRAI), a leader in innovative healthcare technology and Third-Party Administration (TPA) services, today announced second quarter 2025 results that mark a decisive step forward in its turnaround strategy. The Company delivered substantial quarterly year-over-year improvements across key financial metrics: Operating expenses down 70%, saving $9.9 millionOperating loss reduced by 71% to $3.6 million, an $8.7 million improvementNet loss reduced by 66% to $4.4 million, als

    8/13/25 4:07:00 PM ET
    $MRAI
    Misc Health and Biotechnology Services
    Health Care

    MARPAI TO HOST WEBCAST ON AUGUST 14, 2025 TO DISCUSS SECOND QUARTER 2025 FINANCIAL RESULTS

    TAMPA, Fla., Aug. 7, 2025 /PRNewswire/ -- Marpai, Inc. ("Marpai" or the "Company") (OTCQX:MRAI), a leader in innovative healthcare technology and Third-Party Administration (TPA) services. The Company will host a conference call and webcast on Thursday, August 14 at 8:30 a.m. ET to present the Company's operational and financial highlights for Q2 2025. The Company will report its second quarter 2025 results on Wednesday after the market close. Event: Marpai 2025 Q2 Financial Results Conference Call Date: August 14, 2025 Time: 8:30 a.m. Eastern Time Call: US: 1-646-357-8785 / Toll Free: 1-800-836-8184 Webcast: https://app.webinar.net/pD32GbLd5Mx Follow us on X.com and LinkedIn You may strea

    8/7/25 4:03:00 PM ET
    $MRAI
    Misc Health and Biotechnology Services
    Health Care

    Health In Tech Regains Compliance with Nasdaq's Minimum Bid Price Requirement

    STUART, Fla., July 24, 2025 /PRNewswire/ -- Health In Tech (NASDAQ:HIT), an Insurtech platform company backed by third-party AI technology, today announced that it received formal written confirmation from The Nasdaq Stock Market, LLC ("Nasdaq") confirming that the Company has regained compliance with Nasdaq's minimum bid price requirement. To regain compliance with the Minimum Bid Price Requirement, the Company's common shares were required to maintain a minimum closing bid price of $1.00 or more for at least 10 consecutive business days.  The closing bid price of the Shares

    7/24/25 4:30:00 PM ET
    $HIT
    Specialty Insurers
    Finance

    $HIT
    $MRAI
    SEC Filings

    View All

    Health In Tech Inc. filed SEC Form 8-K: Leadership Update

    8-K - Health In Tech, Inc. (0002019505) (Filer)

    8/19/25 6:30:32 AM ET
    $HIT
    Specialty Insurers
    Finance

    SEC Form 10-Q filed by Marpai Inc.

    10-Q - Marpai, Inc. (0001844392) (Filer)

    8/13/25 4:21:08 PM ET
    $MRAI
    Misc Health and Biotechnology Services
    Health Care

    Marpai Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

    8-K - Marpai, Inc. (0001844392) (Filer)

    8/13/25 4:15:30 PM ET
    $MRAI
    Misc Health and Biotechnology Services
    Health Care

    $HIT
    $MRAI
    Leadership Updates

    Live Leadership Updates

    View All

    Health In Tech to Participate as Gold Sponsor at American Trust Investment Services National Conference 2025

    STUART, Fl., May 20, 2025 /PRNewswire/ -- Health In Tech (NASDAQ:HIT), an Insurtech platform company backed by third-party AI technology, today announced that CEO Tim Johnson and CFO Julia Qian will represent the company as a Gold Sponsor at the American Trust Investment Services National Conference 2025, to be held June 16–18, 2025, at the Andaz Hotel in San Diego, California. Hosted by American Trust Investment Services, this exclusive event will bring together registered representatives, advisors, and preferred sponsors for an immersive three-day conference focused on busin

    5/20/25 4:30:00 PM ET
    $HIT
    Specialty Insurers
    Finance

    MARPAI HIRES DALLAS SCRIP AS CHIEF OPERATING OFFICER

    Marpai Bolsters Leadership Team to Drive Profitable High-Growth Strategy with Key Executive Appointment  TAMPA, Fla., May 13, 2025 /PRNewswire/ -- Marpai, Inc. ("Marpai" or the "Company") (OTCQX:MRAI), a leader in innovative healthcare technology and Third-Party Administration (TPA) services, today announced a significant addition to its leadership team with the appointment of Dallas Scrip as Chief Operating Officer (COO) and President of MarpaiRx. This strategic hire underscores Marpai's commitment to accelerating profitable growth and enhancing operational excellence within the dynamic healthcare landscape. Prior to joining Marpai, Mr. Scrip demonstrated significant success in startup, ear

    5/13/25 9:01:00 AM ET
    $MRAI
    Misc Health and Biotechnology Services
    Health Care

    Health In Tech Appoints Former U.S. Ambassador Edward McMullen to Advisory Board

    STUART, Fla., April 30, 2025 /PRNewswire/ -- Health In Tech (NASDAQ:HIT), an Insurtech platform company backed by third-party AI technology, is proud to announce the appointment of Edward T. McMullen Jr., former U.S. Ambassador to Switzerland and Liechtenstein, as a member of its newly formed Advisory Board, effective immediately. Mr. McMullen brings decades of experience in diplomacy, public affairs, and strategic policy, enhancing the company's mission to revolutionize healthcare insurance infrastructure. "Health In Tech is honored to welcome Mr. McMullen to our Advisory Board," said Tim Johnson, Chairman & CEO of Health In Tech. "His deep expertise in public affairs, government relations

    4/30/25 4:30:00 PM ET
    $HIT
    Specialty Insurers
    Finance

    $HIT
    $MRAI
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by Marpai Inc.

    SC 13D/A - Marpai, Inc. (0001844392) (Subject)

    12/9/24 5:14:07 PM ET
    $MRAI
    Misc Health and Biotechnology Services
    Health Care

    Amendment: SEC Form SC 13D/A filed by Marpai Inc.

    SC 13D/A - Marpai, Inc. (0001844392) (Subject)

    9/4/24 7:55:41 PM ET
    $MRAI
    Misc Health and Biotechnology Services
    Health Care

    SEC Form SC 13D/A filed by Marpai Inc. (Amendment)

    SC 13D/A - Marpai, Inc. (0001844392) (Subject)

    5/29/24 4:01:02 PM ET
    $MRAI
    Misc Health and Biotechnology Services
    Health Care

    $HIT
    $MRAI
    Financials

    Live finance-specific insights

    View All

    MARPAI REPORTS SECOND QUARTER 2025 FINANCIAL RESULTS

    Marpai Slashes Losses by Two-Thirds in Q2 2025, Paving the Way to Profitability.Operating Expenses Cut 70% as Turnaround Gains Traction TAMPA, Fla., Aug. 13, 2025 /PRNewswire/ -- Marpai, Inc. ("Marpai" or the "Company") (OTCQX:MRAI), a leader in innovative healthcare technology and Third-Party Administration (TPA) services, today announced second quarter 2025 results that mark a decisive step forward in its turnaround strategy. The Company delivered substantial quarterly year-over-year improvements across key financial metrics: Operating expenses down 70%, saving $9.9 millionOperating loss reduced by 71% to $3.6 million, an $8.7 million improvementNet loss reduced by 66% to $4.4 million, als

    8/13/25 4:07:00 PM ET
    $MRAI
    Misc Health and Biotechnology Services
    Health Care

    MARPAI TO HOST WEBCAST ON AUGUST 14, 2025 TO DISCUSS SECOND QUARTER 2025 FINANCIAL RESULTS

    TAMPA, Fla., Aug. 7, 2025 /PRNewswire/ -- Marpai, Inc. ("Marpai" or the "Company") (OTCQX:MRAI), a leader in innovative healthcare technology and Third-Party Administration (TPA) services. The Company will host a conference call and webcast on Thursday, August 14 at 8:30 a.m. ET to present the Company's operational and financial highlights for Q2 2025. The Company will report its second quarter 2025 results on Wednesday after the market close. Event: Marpai 2025 Q2 Financial Results Conference Call Date: August 14, 2025 Time: 8:30 a.m. Eastern Time Call: US: 1-646-357-8785 / Toll Free: 1-800-836-8184 Webcast: https://app.webinar.net/pD32GbLd5Mx Follow us on X.com and LinkedIn You may strea

    8/7/25 4:03:00 PM ET
    $MRAI
    Misc Health and Biotechnology Services
    Health Care

    Health In Tech Announces Second Quarter 2025 Financial Results

    Revenues of $9.3 million, up 86% YoY; The first-half year revenues of $17.3 million, 89% of full year 2024.Adjusted EBITDA of $1.6 million, up 134% YoY; The first-half year adjusted EBITDA of $2.8 million, 1.2 times full year 2024.Cash balance of $8.1 million.STUART, Fla.  , July 21, 2025 /PRNewswire/ -- Health In Tech (NASDAQ:HIT), an Insurtech platform company backed by third-party AI technology, today announced its financial results for the second quarter ended June 30, 2025. Financial Highlights for the Second Quarter and First-Half of 2025:  Revenues. Total revenues were

    7/21/25 4:30:00 PM ET
    $HIT
    Specialty Insurers
    Finance